NuCana
Company

Last deal

$57M

Amount

Series B

Stage

01.04.2014

Date

2

all rounds

$67.4M

Total amount

date founded

Financing round

General

About Company
NuCana is revolutionizing cancer treatment by transforming widely used chemotherapy agents into safer and more effective medicines.

Industry

Sector :

Subsector :

Also Known As

Nucana Biomed

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

As a clinical-stage biopharmaceutical company, NuCana is leveraging its proprietary ProTide technology to develop innovative cancer treatments. By applying phosphoramidate chemistry, the company aims to overcome resistance mechanisms and enhance the concentration of anti-cancer metabolites in cancer cells. With a focus on improving treatment outcomes for cancer patients, NuCana operates primarily in the United States.
Contacts

Contact Email

Phone number

Social url

Legal Names

Legal name

NuCana PLC
Similar Companies
1000
NuCana BioMed

NuCana BioMed

NuCana BioMed develops innovative medicines to treat unmet medical needs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Edinburgh, UK

total rounds

5

total raised

$347.53M
Arena Pharmaceuticals

Arena Pharmaceuticals

Arena Pharmaceuticals is a clinical-stage biotech company that focuses on developing solutions for various diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

San Diego, CA, USA

total rounds

8

total raised

$1.06B

count Of Investments

1
Spexis

Spexis

Spexis is a Swiss biopharmaceutical company that develops transformative biotechnological medicines.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

4123 Allschwil, Switzerland
Faron Pharmaceuticals

Faron Pharmaceuticals

Faron is a clinical stage biopharmaceutical company developing innovative treatments for medical conditions with significant unmet needs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Turku, Finland

total rounds

10

total raised

$66.31M

Financials

Funding Rounds
2
2

Number of Funding Rounds

$67.4M

Money Raised

Their latest funding was raised on 01.04.2014. Their latest investor Scottish Investment Bank. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Sofinnova Investments

Sofinnova Investments

Sofinnova Investments is a venture capital firm that specializes in funding and supporting Life Science and Technology start-ups.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Menlo Park, CA, USA

count Of Investments

236

count Of Exists

58
Sofinnova Partners

Sofinnova Partners

Sofinnova Partners is a venture capital firm that invests in life sciences.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Paris, France

total rounds

1

count Of Investments

287

count Of Exists

40
Co-Investors
Investors
6
2

Number of lead investors

6

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series A, Series B
No
Series B
Scottish Investment Bank

Scottish Investment Bank

Scottish Investment Bank is a Glasgow-based venture capital subsidiary that invests in small- and medium-sized businesses.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Glasgow, UK

count Of Investments

301

count Of Exists

36

Morningside Ventures

Morningside Ventures is an investment firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

count Of Investments

32
Scottish Enterprise

Scottish Enterprise

Scottish Enterprise partners with public and private sectors to stimulate Scotland's economic ambition.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Location

Glasgow, UK

count Of Investments

283

count Of Exists

18

People

Founders
1
Hugh Griffith
Hugh Griffith

Hugh Griffith

Hugh Griffith has over twenty years experience in the biopharmaceutical industry, having held CEO, COO and Executive Director positions. Hugh is Co-Founder and CEO of NuCana. Hugh led Bioenvision's operations, from start-up to a global, fully integrated, NASDAQ National Market listed biopharmaceutical company. He was instrumental in increasing Bioenvision's market capitalization from $22 million to $345 million in five years, culminating in the company's successful acquisition. Hugh supports a number of early stage biopharmaceutical companies as co-founder, director, investor and/or advisor. He is CEO & Gatekeeper for Alida Capital International, a specialist biopharmaceutical business angel syndicate. Hugh has wide pharmaceutical experience having held numerous positions in Abbott Laboratories, Parke-Davis Warner Lambert and QuantaNova. He currently serves on the: Angel Leaders Forum; Scottish LifeSciences Association Board; LiSAB technology and capital workstreams; Chairs SLA Finance SIG; and as advisor to the Saltire Foundation. Hugh holds a Masters of Business Administration from Cardiff Business School and a BSc Honours in Biology from the University of Stirling.

current job

Alida Capital International

organization founded

2

Hugh Griffith

Employee Profiles
4
Jeffrey Bloss

Jeffrey Bloss

Chief Medical Officer

Danielle Mclean

Principal medical writer

Don Munoz

Don Munoz

Chief Financial Officer

Hugh Griffith

Hugh Griffith

CEO & Founder

Activity

Recent News
1